News for OPTHEA LIMITED (CKDXF)

Baseline angiographic lesion characteristics predictive of clinical response Published in peer-reviewed journal Ophthalmic Surgery, Lasers and Imaging Reti

Cash and cash equivalents of $131.9M as of December 31, 2024 Cash runway extends through anticipated topline data readouts of COAST (early 2Q CY25) and ShORe (

Three consecutive commercial-scale drug product batches successfully produced Supports potential sozinibercept BLA filing in 1H CY2026 MELBOURNE, Australia

COAST Phase 3 trial evaluates superiority and safety of sozinibercept combined with aflibercept in wet AMD Company confirms topline results for COAST a

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at where Opthea Limited (NASDAQ:OPT) stands against the other long term ASX stocks...

**media[534928]**

MELBOURNE, Australia and PRINCETON, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/OPT, ”œOpthea”, the ”œCompany”), a clinical-stage biopha

We recently compiled a list of the 10 Best ASX Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Opthea Limited (NASDAQ:OPT) stands against other best ASX...

**media[509148]**

**media[507938]**

Phase 1b clinical data underpins sozinibercept's potential as a novel, first-in-class VEGF-C/D ”˜trap' to improve visual and anatomic outcomes in DME Publis

**media[476519]**

MELBOURNE, Australia and PRINCETON, N.J., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Opthea Limited (ASX/OPT, ”œOpthea”, the ”œCompany”), a clinical-stage biopha

**media[467153]**

Opthea adds Kathy Connell to Board of Directors

**media[438222]**

VEGFR2 (vascular endothelial growth factor receptor 2) antagonist is an antineoplastic agent that blocks the binding of natural VEGF ligands, which are...

In this piece, we will take a look at the 11 best ASX stocks to buy now.

The increasing number of diagnosed cases of wet AMD, the current therapies, and the launch of emerging therapies will drive the wet AMD market growth in...